Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Deficiency, Platelet Phenotype and Thromboembolism in Cancer Patients
2012-002981-11Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA) and colorectal cancer (CRC), sponsored by Medical University of Vienna. Primary endpoint: drop in platelet counts>10%. Started Sep 2013; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)colorectal cancer (CRC)
Beyond the preview
Go deeper on 2012-002981-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002981-11.